Model DetailsLeukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma
Model Name |
Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Strain |
CD-1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
hematopoietic/lymphoreticular histiocytic sarcoma • hematopoietic neoplasm • histiocytic sarcoma • histiocytic sarcoma, systemic • hematopoietic tumor • systemic histiocytic sarcoma • hemato neoplasia, sarcoma, histiocytic |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0.6% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
1.9% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
2.7% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
0.9% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0% (0 of 59 mice) |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
5.1% (3 of 59 mice) |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
6.7% (4 of 60 mice) |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
0% (0 of 60 mice) |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
2.3% (17 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
5.5% (40 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0% (0 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
1.7% (1 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
1.7% (1 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
15% (9 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0% (0 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
6.7% (4 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
0% (0 of 31 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
0% (0 of 23 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
0% (0 of 54 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
3.2% (1 of 31 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0% (0 of 21 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
1.9% (1 of 52 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0% (0 of 1453 mice) |
up to 40 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0.14% (2 of 1453 mice) |
up to 50 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
0% (0 of 1453 mice) |
up to 40 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
0.14% (2 of 1453 mice) |
up to 50 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |